{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:19:36Z","timestamp":1777457976099,"version":"3.51.4"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T00:00:00Z","timestamp":1680739200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010591","name":"Tiroler Wissenschaftsfonds","doi-asserted-by":"crossref","award":["GZ: UNI-0404-1983"],"award-info":[{"award-number":["GZ: UNI-0404-1983"]}],"id":[{"id":"10.13039\/501100010591","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Neurodevelopmental impairment is a significant complication among survivors of preterm birth. To improve outcomes, reliable biomarkers for early detection of brain injury and prognostic assessment are required. Secretoneurin is a promising early biomarker of brain injury in adults and full-term neonates suffering from perinatal asphyxia. Data on preterm infants is currently lacking. The aim of this pilot study was to determine secretoneurin concentrations in preterm infants in the neonatal period, and to assess secretoneurin\u2019s potential as a biomarker of preterm brain injury. We included 38 very preterm infants (VPI) born at &lt;32 weeks\u2019 gestation in the study. Secretoneurin concentrations were measured in serum samples obtained from the umbilical cord, at 48 hours and 3 weeks of life. Outcome measures included repeated cerebral ultrasonography, magnetic resonance imaging at term-equivalent age, general movements assessment, and neurodevelopmental assessment at a corrected age of 2 years by the Bayley Scales of Infant and Toddler Development, third edition (Bayley-III). In comparison to a term-born reference population, VPI had lower secretoneurin serum concentrations in umbilical cord blood and blood collected at 48 hours of life. When measured at 3 weeks of life, concentrations correlated with gestational age at birth. Secretoneurin concentrations did not differ between VPI with an imaging-based diagnosis of brain injury and those without, but when measured in umbilical cord blood and at 3 weeks of life correlated with and were predictive of Bayley-III motor and cognitive scale scores. Secretoneurin levels in VPI differ from term-born neonates. Secretoneurin seems unsuitable as a diagnostic biomarker of preterm brain injury, but bears some prognostic potential and is worthy of further investigation as a blood-based biomarker of preterm brain injury.<\/jats:p>","DOI":"10.1371\/journal.pone.0284096","type":"journal-article","created":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T17:39:43Z","timestamp":1680802783000},"page":"e0284096","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Investigation of secretoneurin as a potential biomarker of brain injury in very preterm infants: A pilot study"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1008-3375","authenticated-orcid":true,"given":"Anna","family":"Posod","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina","family":"Wechselberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmin","family":"Pellkofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlene","family":"Hammerl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Urbanek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Huber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula","family":"Kiechl-Kohlendorfer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9269-5756","authenticated-orcid":true,"given":"Elke","family":"Griesmaier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2023,4,6]]},"reference":[{"issue":"Suppl 1","key":"pone.0284096.ref001","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1742-4755-10-S1-S2","article-title":"Born too soon: the global epidemiology of 15 million preterm births","volume":"10","author":"H Blencowe","year":"2013","journal-title":"Reprod Health"},{"issue":"1","key":"pone.0284096.ref002","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2016.01.004","article-title":"Preterm neonatal morbidity and mortality by gestational age: a contemporary cohort","volume":"215","author":"TA Manuck","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"pone.0284096.ref003","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1001\/jama.2015.10244","article-title":"Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993\u20132012","volume":"314","author":"BJ Stoll","year":"2015","journal-title":"JAMA"},{"key":"pone.0284096.ref004","article-title":"Two-year neurodevelopmental outcome in children born extremely preterm: the EPI-DAF study","author":"PE van Beek","year":"2022","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"5","key":"pone.0284096.ref005","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/apa.14209","article-title":"Impaired cognitive ability at 2.5 years predicts later visual and ophthalmological problems in children born very preterm","volume":"107","author":"J Hreinsdottir","year":"2018","journal-title":"Acta Paediatr"},{"key":"pone.0284096.ref006","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.pediatrneurol.2019.02.016","article-title":"Dysmaturation of Premature Brain: Importance, Cellular Mechanisms, and Potential Interventions","volume":"95","author":"JJ Volpe","year":"2019","journal-title":"Pediatr Neurol"},{"issue":"8","key":"pone.0284096.ref007","doi-asserted-by":"crossref","DOI":"10.3390\/cells9081871","article-title":"Preterm Brain Injury, Antenatal Triggers, and Therapeutics: Timing Is Key","volume":"9","author":"D Ophelders","year":"2020","journal-title":"Cells"},{"issue":"3","key":"pone.0284096.ref008","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/archdischild-2020-319450","article-title":"Neuroscience meets nurture: challenges of prematurity and the critical role of family-centred and developmental care as a key part of the neuroprotection care bundle","volume":"107","author":"R Soni","year":"2022","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"1","key":"pone.0284096.ref009","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/apa.12828","article-title":"Cerebral tissue oxygen saturation is associated with N-terminal probrain natriuretic peptide in preterm infants on their first day of life","volume":"104","author":"C Binder-Heschl","year":"2015","journal-title":"Acta Paediatr"},{"key":"pone.0284096.ref010","doi-asserted-by":"crossref","first-page":"634092","DOI":"10.3389\/fped.2021.634092","article-title":"Precision Medicine in Neonates: A Tailored Approach to Neonatal Brain Injury","volume":"9","author":"ML Tataranno","year":"2021","journal-title":"Front Pediatr"},{"issue":"10","key":"pone.0284096.ref011","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1007\/s00134-014-3423-4","article-title":"Secretoneurin as a marker for hypoxic brain injury after cardiopulmonary resuscitation","volume":"40","author":"J Hasslacher","year":"2014","journal-title":"Intensive Care Med"},{"issue":"1","key":"pone.0284096.ref012","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1172\/JCI32723","article-title":"Secretoneurin promotes neuroprotection and neuronal plasticity via the Jak2\/Stat3 pathway in murine models of stroke","volume":"118","author":"WC Shyu","year":"2008","journal-title":"J Clin Invest"},{"issue":"1","key":"pone.0284096.ref013","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000444245","article-title":"Secretoneurin Serum Levels in Healthy Term Neonates and Neonates with Hypoxic-Ischaemic Encephalopathy","volume":"110","author":"K Wechselberger","year":"2016","journal-title":"Neonatology"},{"issue":"4","key":"pone.0284096.ref014","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2174\/1389203054546334","article-title":"Secretoneurin: a new player in angiogenesis and chemotaxis linking nerves, blood vessels and the immune system","volume":"6","author":"R Fischer-Colbrie","year":"2005","journal-title":"Curr Protein Pept Sci"},{"issue":"1","key":"pone.0284096.ref015","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.clp.2013.09.004","article-title":"Pharmacologic neuroprotective strategies in neonatal brain injury","volume":"41","author":"SE Juul","year":"2014","journal-title":"Clin Perinatol"},{"issue":"2","key":"pone.0284096.ref016","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0306-4522(93)90200-Y","article-title":"Secretoneurin\u2014a neuropeptide generated in brain, adrenal medulla and other endocrine tissues by proteolytic processing of secretogranin II (chromogranin C)","volume":"53","author":"R Kirchmair","year":"1993","journal-title":"Neuroscience"},{"issue":"4","key":"pone.0284096.ref017","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0022-3476(78)80282-0","article-title":"Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm","volume":"92","author":"LA Papile","year":"1978","journal-title":"J Pediatr"},{"key":"pone.0284096.ref018","unstructured":"Volpe JJ. Volpe\u2019s Neurology of the Newborn. (Ed) t, editor2018."},{"issue":"1","key":"pone.0284096.ref019","doi-asserted-by":"crossref","first-page":"e0169442","DOI":"10.1371\/journal.pone.0169442","article-title":"Routine Magnetic Resonance Imaging at Term-Equivalent Age Detects Brain Injury in 25% of a Contemporary Cohort of Very Preterm Infants","volume":"12","author":"V Neubauer","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"pone.0284096.ref020","doi-asserted-by":"crossref","first-page":"e444","DOI":"10.1542\/peds.2013-2336","article-title":"Brain injury and altered brain growth in preterm infants: predictors and prognosis","volume":"134","author":"H Kidokoro","year":"2014","journal-title":"Pediatrics"},{"issue":"3","key":"pone.0284096.ref021","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/j.jped.2015.12.003","article-title":"Fidgety movements\u2014tiny in appearance, but huge in impact","volume":"92","author":"C Einspieler","year":"2016","journal-title":"J Pediatr (Rio J)"},{"issue":"4","key":"pone.0284096.ref022","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/archpediatrics.2010.25","article-title":"Measuring outcomes after extreme prematurity with the Bayley-III Scales of infant and toddler development: a cautionary tale from Australia","volume":"164","author":"ME Msall","year":"2010","journal-title":"Arch Pediatr Adolesc Med"},{"key":"pone.0284096.ref023","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2431-13-59","article-title":"A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants","volume":"13","author":"TR Fenton","year":"2013","journal-title":"BMC Pediatr"},{"issue":"2","key":"pone.0284096.ref024","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0165-3806(97)00042-4","article-title":"Ontogenic development of secretogranin II and of its processing to secretoneurin in rat brain","volume":"100","author":"B Leitner","year":"1997","journal-title":"Brain Res Dev Brain Res"},{"issue":"4","key":"pone.0284096.ref025","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.spen.2009.09.005","article-title":"The encephalopathy of prematurity\u2014brain injury and impaired brain development inextricably intertwined","volume":"16","author":"JJ Volpe","year":"2009","journal-title":"Semin Pediatr Neurol"},{"issue":"3","key":"pone.0284096.ref026","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000506836","article-title":"Supratentorial Brain Metrics Predict Neurodevelopmental Outcome in Very Preterm Infants without Brain Injury at Age 2 Years","volume":"117","author":"M Hammerl","year":"2020","journal-title":"Neonatology"},{"key":"pone.0284096.ref027","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.neuroscience.2019.05.023","article-title":"Excitotoxicity Alters Endogenous Secretoneurin Plasma Levels, but Supplementation with Secretoneurin Does Not Protect Against Excitotoxic Neonatal Brain Injury","volume":"410","author":"A Posod","year":"2019","journal-title":"Neuroscience"},{"issue":"3\u20134","key":"pone.0284096.ref028","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000244055","article-title":"Epidemiology and pathophysiology of apnoea of prematurity","volume":"65","author":"CF Poets","year":"1994","journal-title":"Biol Neonate"},{"issue":"10","key":"pone.0284096.ref029","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1097\/CCM.0000000000001832","article-title":"Prognostic Value of Secretoneurin in Critically Ill Patients With Infections","volume":"44","author":"H Rosjo","year":"2016","journal-title":"Crit Care Med"},{"issue":"5","key":"pone.0284096.ref030","doi-asserted-by":"crossref","first-page":"e404","DOI":"10.1097\/CCM.0000000000003050","article-title":"Prognostic Value of Secretoneurin in Patients With Severe Sepsis and Septic Shock: Data From the Albumin Italian Outcome Sepsis Study","volume":"46","author":"H Rosjo","year":"2018","journal-title":"Crit Care Med"},{"issue":"4","key":"pone.0284096.ref031","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jacc.2014.10.065","article-title":"Secretoneurin is a novel prognostic cardiovascular biomarker associated with cardiomyocyte calcium handling","volume":"65","author":"AH Ottesen","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"pone.0284096.ref032","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.clinbiochem.2019.06.008","article-title":"Circulating secretoneurin concentrations in patients with moderate to severe aortic stenosis","volume":"71","author":"J Brynildsen","year":"2019","journal-title":"Clin Biochem"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0284096","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T17:40:12Z","timestamp":1680802812000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0284096"}},"subtitle":[],"editor":[{"given":"Giuseppe","family":"Biagini","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,4,6]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0284096","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,6]]}}}